PMS-EVEROLIMUS

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 8484a2ba0c2edb2d
Drug Approval Canada Name: PMS-EVEROLIMUS
Product Name: PMS-EVEROLIMUS
Status: Marketed
Status Date: 2021-09-08
Original Market Date: 2021-09-08
Din: 02504677
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L04AH02 EVEROLIMUS
Atc Name: l 04 ah 02
Aig Number: 0152682003
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

EVEROLIMUS

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

8484a2ba0c2edb2d

Type

Standard